|
Friday, 03 September 2010 18:43 |
 HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™), today announced the appointments of John Wineman as Vice President New Business Development, Western Region and Thomas Vasicek, Ph.D., as Vice President Clinical Programs and Product Innovation.
|
|
Read more...
|
|
Wednesday, 01 September 2010 13:09 |
 James Lally, DO, MMM, President and Chief Medical Officer of Chino Valley Medical Center and an alumnus of Western University of Health Sciences' College of Osteopathic Medicine of the Pacific (COMP), has been named president of the American Osteopathic Foundation (AOF). Dr. Lally will lead the organization until Dec. 31, 2011.
|
|
Read more...
|
|
Monday, 30 August 2010 18:02 |
 Celgene Corporation (NASDAQ: CELG) today announced the appointment of Jacqualyn A. Fouse as Senior Vice President and Chief Financial Officer, effective September 27, 2010. Ms. Fouse will be responsible for all finance operations at Celgene and will report to Robert J. Hugin, Chief Executive Officer of Celgene Corporation.
|
|
Read more...
|
|
Friday, 27 August 2010 17:27 |
 Today, NeuroSearch A/S (NEUR), a leading CNS focused and European based biopharmaceutical company announced the appointment of Patrik Dahlen as new CEO of the company. With effect from 15 September 2010, Patrik Dahlen will replace CEO Flemming Pedersen, who resigns to take up a new position in another company.
|
|
Read more...
|
|
Wednesday, 25 August 2010 18:19 |
 AnaSpec’s general manager, Dr. Anita Hong and technical support specialist, Cecilia Po, visited the highly published and eminent Alzheimer’s researcher, Dr. Patrick McGeer and his associate, Dr. Jian-Ping Guo at the University of British Columbia,
|
|
Read more...
|
|
Monday, 23 August 2010 18:34 |
 ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Mr. Alan Morgan to the position of Group President, Clinical Research Services.
|
|
Read more...
|
|
Friday, 20 August 2010 18:01 |
 Euthymics Bioscience, Inc., a clinical-stage company developing next-generation antidepressants, today announced that Pierre Trân, M.D., and Joan Manthis have been appointed as Chief Medical Officer and Director of Clinical Operations, respectively.
|
|
Read more...
|
|
Wednesday, 18 August 2010 12:45 |
 Further to the announcement made on 5th May 2010, SkyePharma PLC (LSE:SKP) announces today that it has appointed Dr. Axel Müller as Chief Executive Officer with effect from 23rd August 2010.
|
|
Read more...
|
|
Friday, 13 August 2010 13:15 |
 OXIS INTERNATIONAL, INC.(OTC Bulletin Board: OXIS, Paris: OXI) announced today the addition of Dr. Stephen Coles as the newest member to its Scientific Advisory Board. The addition of Dr. Coles given his extensive research in the area of DNA, RNA and anti-aging will prove to be extremely beneficial in the company's product rollout.
|
|
Read more...
|
|
Wednesday, 11 August 2010 18:36 |
 Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the appointment of Michael J. Gallagher, MD, as Vice President and Global Head, Medical Affairs.
|
|
Read more...
|
|
|
Friday, 03 September 2010 13:40 |
 MethylGene Inc. (TSX: MYG) today announced the appointment of Dr. Martin Godbout as Chairman of the Board of Directors of the Corporation, effective immediately. Dr. Godbout has been a member of MethylGene's Board of Directors since 2002. MethylGene's Board now numbers seven.
|
|
Read more...
|
|
Wednesday, 01 September 2010 12:07 |
 King Pharmaceuticals, Inc. (NYSE: KG) announced today the appointment of Jeffrey A. Bailey to the position of Chief Commercial Officer. Mr. Bailey will be responsible for the Company's commercial activities in the branded pharmaceutical business and will lead all Sales, Marketing, Managed Care, Sales Operations and Business Analytics.
|
|
Read more...
|
|
Monday, 30 August 2010 16:56 |
 XenoPort, Inc. /quotes/comstock/15*!xnpt/quotes/nls/xnpt (XNPT 6.18, -0.04, -0.64%) announced today that William J. Rieflin has been elected to the XenoPort Board of Directors, effective September 17, 2010, and he will resign as president of XenoPort to accept a position as chief executive officer of a private biotech company.
|
|
Read more...
|
|
Friday, 27 August 2010 16:25 |
 Emergent BioSolutions Inc. (NYSE:EBS) announced today that the company’s Board of Directors appointed John E. Niederhuber, M.D. as a Class III Director for a two-year term that will expire at the 2012 annual meeting of stockholders.
|
|
Read more...
|
|
Wednesday, 25 August 2010 17:15 |
 Torbjorn Bjerke has been appointed as new CEO for Karolinska Development. He is currently CEO for Orexo, a position he has held since 2007. Torbjorn Bjerke succeeds Conny Bogentoft who will assume the position as Chief Scientific Officer for Karolinska Development.
|
|
Read more...
|
|
Monday, 23 August 2010 12:37 |
 The board of directors of Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced that Christopher B. Begley, chairman and chief executive officer (CEO), has indicated his intent to retire from the CEO position after more than six years of dedicated service.
|
|
Read more...
|
|
Friday, 20 August 2010 12:03 |
 Limerick BioPharma, Inc., a developer of innovative therapies that help cells pump unwanted or toxic substances away from vulnerable tissues, has announced that Jill Carroll has joined the firm as Vice President of Strategic Corporate Development.
|
|
Read more...
|
|
Monday, 16 August 2010 18:38 |
 RNA Networks, Inc., the leader in memory virtualization, announced today that Michael Keddington has joined the company as CEO. Keddington takes the reins of the company as it enters a new phase of growth after the announcement of its RNA MVX 2.5 solution.
|
|
Read more...
|
|
Friday, 13 August 2010 12:10 |
|
Bionovo, Inc. (Nasdaq: BNVI) announced today the appointment of James H. Pickar, M.D. to the company's Medical Advisory Board. Dr. Pickar is a world renowned leader and researcher in the area of women's health.
|
|
Read more...
|
|
Wednesday, 11 August 2010 12:39 |
 Fluxion Biosciences, Inc. announced today that Steve Smith, Ph.D., has joined its management team as head of IonFlux sales and will lead sales and application efforts for the IonFlux automated patch clamp system.
|
|
Read more...
|
|
